In this episode of the No-BS AI Briefing, Vikash unpacks Google's new TPU 8 chips, specifically engineered for agentic AI workloads, promising significantly reduced costs and improved performance for builders. We also cover the exciting news of Isomorphic Labs moving AI-designed drugs into human trials, marking a major milestone in applied AI. Plus, discover OpenAI's GPT-Image-2 API, designed for iterative production workflows, and the critical governance lessons emerging from the Musk vs. OpenAI trial. Vikash offers a practical takeaway: prototype a multi-step agent workflow to baseline costs for future AI advancements. Follow the show for more concise, opinionated briefings that keep you ahead without drowning you in noise.

Send us Fan Mail

Support the show